
A 1,000-X-ray blob: Why Chernobyl's Elephant's Foot still terrifies scientists
Tired of too many ads?
Remove Ads
A silent killer made of stone and fire
Tired of too many ads?
Remove Ads
The brave who filmed the unfilmable
Radiation on film and memory
A disaster still unfolding
Tired of too many ads?
Remove Ads
War reawakens the danger
In 1986, a nuclear explosion rocked Reactor 4 of the Chernobyl power plant. In the immediate aftermath, radiation swept across what was then the Soviet Union. Among the remnants of the disaster was the formation of one of the deadliest objects on Earth—now known as the 'Elephant's Foot'. This mass of nuclear sludge, born from molten core material and reactor debris, still lies beneath the plant, a haunting symbol of the world's worst nuclear accident.Shortly after the meltdown, strange molten structures began forming in the plant's lower levels. One such mass—shaped eerily like the foot of an elephant—solidified into what scientists later identified as corium. A searing combination of uranium, zirconium, graphite, steel, and sand, this highly radioactive sludge oozed its way through the reactor's pipes before cooling in the basement.At its peak, the Elephant's Foot emitted over 10,000 roentgens of radiation per hour—enough to kill a human in minutes. Experts likened the exposure to enduring 4.5 million chest X-rays in one sitting. Early symptoms of exposure included vomiting, diarrhoea, and fever. Scientists said being near it for five minutes could have resulted in death within two days.Even today, while the radiation has decayed, the site remains dangerous. The corium is now 'more or less has the consistency of sand,' said Maxim Saveliev from the Institute for Safety Problems of Nuclear Power Plants.Yet, despite its lethality, several individuals ventured close enough to photograph and study it—often at great personal cost.One of the most iconic recordings was made in 1996 by Artur Korneyev , a Kazakhstani radiation specialist. Donning a hazmat suit, he and his team descended into the flooded, rust-streaked depths beneath Reactor 4. The footage he captured is grainy, ghostly, and claustrophobic—filled with metallic remnants and spider webs. But at its centre sits the Elephant's Foot.'We had to use a Kalashnikov to chip pieces off,' said one scientist, referring to how dense the corium had become.Korneyev later joked about his condition from radiation exposure : 'Soviet radiation is the best radiation in the world,' he told The New York Times. He is believed to have died in 2022 at age 73.Three years after the disaster, physics technician Alexander Kupny volunteered to document Reactor 4's remains. In 1989, he ventured inside multiple times, managing to avoid acute radiation syndrome by limiting exposure. Kupny's footage, often taken from behind thick concrete or with remote cameras, has circulated online. Viewers noted how radiation warped the footage.'The white specks on screen is not the camera quality, but in fact the radiation messing with the film/camera itself,' commented one viewer on YouTube.'These folks sacrificed their own health and potentially their own life to record footage of this disaster. Mad respect,' said another.Even earlier, just days after the explosion, Soviet filmmaker Vladimir Shevchenko filmed the 30-kilometre Exclusion Zone from above. His 35mm footage carried ghostly static and distortion. It was only later that he understood: he had captured radiation itself on film.The long-term impact of Chernobyl is grim. The United Nations reported that over 400,000 people were relocated from the surrounding areas. More than 500,000 firefighters and cleanup personnel were exposed to high radiation. While 31 died in the immediate aftermath, estimates of eventual deaths range between 4,000 and 60,000. Thousands of thyroid cancer cases have been traced back to contamination from the explosion.Only four other known corium formations have ever emerged during nuclear meltdowns in history. None have the notoriety or public recognition of the Elephant's Foot.Despite the decades that have passed, Chernobyl remains a flashpoint. In 2022, during Russia's invasion of Ukraine, Russian troops took control of the plant—raising alarms worldwide. Ukrainian staff warned that if the generators failed, the consequences 'could have been catastrophic.' Reports emerged that Russian soldiers dug trenches in the Exclusion Zone and may have been exposed to 'significant doses' of radiation.Once again, the world was reminded: Chernobyl is not in the past.It is still a wound, open and radioactive.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
15 hours ago
- Business Standard
Apollo, Siemens collaborate to advance liver healthcare with AI innovation
Apollo Hospitals and Siemens Healthineers on Wednesday announced a research collaboration founded on a shared ambition to advance innovations in artificial intelligence (AI) and imaging technologies, with the goal of improving lives. The research, spanning quantitative ultrasound imaging to AI-driven clinical solutions, aims to enhance liver disease management by improving patient care pathways and outcomes—from early detection and risk stratification to monitoring intervention and therapy response. The partnership combines technical and clinical expertise to develop innovative healthcare solutions for the growing burden of liver diseases in India, with a focus on early diagnosis, accurate detection, and precise monitoring to improve patient outcomes. As per Government of India guidelines, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), referred to as NAFLD in the report, is a growing cause of liver disease in India. Its prevalence ranges from 9 per cent to 32 per cent and is higher among individuals who are overweight, obese, or have diabetes. According to NFHS-4 (2015–2016), 18–20 per cent of adults are overweight or obese and 3–8 per cent have abnormal blood sugar levels. MASLD significantly increases cardiovascular risk, with heart disease being the leading cause of death. 'At Apollo, we believe that the future of healthcare lies at the intersection of clinical excellence and cutting-edge technology anchored in patient centricity. Our collaboration with Siemens Healthineers is a transformative step in using AI to redefine non-invasive diagnostics for liver disease. Due to diagnostic challenges and the evolving understanding of the disease, the true prevalence of MASLD may be underestimated. This poses a significant public health challenge, requiring increased awareness, early detection, and effective management strategies,' said Sangita Reddy, joint managing director, Apollo Hospitals. 'AI-driven disease progression models will play a pivotal role in the early detection of fibrosis, allowing timely interventions, cost-effective screening, and improved patient outcomes. These models will also facilitate precision population health strategies and clinical decision support across care settings. This partnership reflects Apollo's pioneering vision to embed intelligent systems across the clinical spectrum that enable faster, more accurate diagnoses and proactive patient management,' she added. 'Liver disease is a growing health concern in India. It's crucial to prioritise early diagnosis and prevention through advanced diagnostic tools, lifestyle changes, and increased awareness to reverse this trend. We believe that advanced technologies will aid timely and precise diagnosis, leading to better disease management and improved quality of life for patients. Our joint effort will help address the unmet needs in liver disease diagnosis and treatment, and we look forward to a fruitful partnership,' said Hariharan Subramanian, managing director, Siemens Healthcare. Following the 2024 memorandum of understanding, the Master Research Agreement (MRA) was formalised in March 2025, establishing a foundation for collaborative research in diagnostic and interventional ultrasound imaging. The signing ceremony for the MRA addendum was held on July 23, 2025, in Hyderabad, marking a significant milestone in this partnership.


Fibre2Fashion
15 hours ago
- Fibre2Fashion
Godavari Biorefineries gets Chinese patent for cancer molecule
Godavari Biorefineries Limited (BSE: 544279 | NSE: GODAVARIB), through its clinical-stage biotech division Sathgen Therapeutics, has been granted a patent by the China National Intellectual Property Administration (CNIPA), China's patent and trademark office for its novel anti-cancer molecule - HYDROXY-1,4-NAPHTHALENEDIONE. This patent covers a novel class of compounds that have exhibited strong inhibitory effects on cancer and cancer stem cells in vitro studies. These compounds have demonstrated significant efficacy against multiple cancer cell types, including breast and prostate cancer. 'Our focus on original, high-quality science continues to guide our journey beyond green chemistry into life sciences,' said Dr Sangeeta Srivastava, Executive Director, Godavari Biorefineries Limited. 'This Chinese patent reinforces the promise of our lead molecule and the vital work being done by our team at Sathgen Therapeutics to develop innovative therapies for some of the most pressing medical needs worldwide.' Godavari Biorefineries has established a global presence, exporting to over 20 countries and maintaining strong linkages with international research and development networks. The company's clinical-stage biotech division, Sathgen Therapeutics, is at the forefront of advancing novel cancer and antiviral therapies. With a lead molecule undergoing clinical trials and global patent protection, GBL is deepening its focus in translational research that addresses some of the world's most urgent health challenges. Note: The headline, insights, and image of this press release may have been refined by the Fibre2Fashion staff; the rest of the content remains unchanged. Godavari Biorefineries' biotech arm, Sathgen Therapeutics, has secured a Chinese patent for its anti-cancer molecule Hydroxy-1,4-Naphthalenedione. The compound shows strong in vitro efficacy against cancer and cancer stem cells. GBL continues to expand globally, focusing on innovative cancer and antiviral therapies through advanced translational research. ALCHEMPro News Desk (HU)


NDTV
16 hours ago
- NDTV
A Daughter Of India Soon To Touch The Stars. ISRO, Government Determined
New Delhi: India's space odyssey is poised to take a historic leap forward, one that would include the country's daughters among its astronauts. In an exclusive conversation with Air Vice Marshal Anupam Agarwal, Assistant Chief of Air Staff (Medical) and a leading space medicine expert, the roadmap for India's inclusive future in space was laid out with clarity and conviction. India will soon get women astronauts as part of Gaganyaan. The Axiom-4 flight, often referred to as Mission Akash Ganga, has already made headlines with the successful return of Group Captain Shubhanshu Shukla from the International Space Station. But this is the beginning of an entire process, one that would include women, civilians, and people from all walks of life. Why No Women in the First Cohort The absence of women in the initial astronaut cohort has sparked questions and debate. Air Vice Marshal Agarwal addressed this directly, explaining the constraints faced during the selection process in 2019. "These are unprecedented situations," he said. "When you are building space systems from the ground up, there are many variables that are difficult to fathom at the beginning," he said. In 2019, the Indian Air Force had only male test pilots. Since the first mission required individuals with highly specialized skills to handle unknown and potentially dangerous scenarios, the selection was limited to test pilots. "A test pilot is someone you ask to fly an aircraft that's never flown before, he or she will do it at 1000 kilometres an hour, and land it safely," Air Vice Marshal Agarwal explained. "You need such a person when you're making a spacecraft for the first time. You're not sure about the systems inside it." This skill set, reflexes, adaptability, and the ability to remain calm under pressure, is critical. And in 2019, the pool of qualified candidates with these attributes consisted solely of men. "We didn't have a choice," Air Vice Marshal Agarwal said. "There were no female test pilots in the Indian Armed Forces at that time." Even today, while there are several women fighter pilots in the Indian Air Force, none have reached the seniority level to qualify as test pilots -- which has very stringent qualifying criteria. Global Indians The American space agency NASA has flown women of Indian origin to space like late Astronaut Kalpana Chawla and Astronaut Sunita Williams, but both were citizens of USA. A Future That Includes India's Daughters Despite these initial limitations, the future is bright and inclusive. Air Vice Marshal Agarwal confirmed that women will soon join the astronaut corps. "ISRO has been very particular that we need to be inclusive," he said. "And the Government of India has emphasized this as well. If I dare to look into the future, we should have women soon," he said. Speaking from the ramparts of the Red Fort on Independence Day in 2018, Prime Minister Narendra Modi had also asserted: "We have a dream. Our scientists have a dream. We have resolved... some of our young boys and girls will unfurl the Tricolour in space." This commitment to inclusion is not just symbolic - it reflects a broader expansion of India's vision for space exploration. Future astronauts may not necessarily be scientists or engineers. They could be civilians, educators, artists, or individuals from other professions, representing the full spectrum of Indian society. "India's daughter will go to space soon. This is the order of the Indian government. She will come," Air Vice Marshal said.